Bone TransplantationBone BanksTransplantation, HomologousBone Marrow TransplantationBone and BonesGraft vs Host DiseaseLiver TransplantationHematopoietic Stem Cell TransplantationTransplantation ConditioningKidney TransplantationTransplantation, AutologousGraft SurvivalTransplantation ChimeraTissue DonorsBone RemodelingHeart TransplantationWhole-Body IrradiationStem Cell TransplantationBone MarrowGraft RejectionLung TransplantationLeukemiaTransplantation ImmunologyBone Marrow CellsTransplantation, IsogeneicBone DensityImmunosuppressive AgentsHistocompatibility TestingHematologic NeoplasmsGraft vs Tumor EffectRecurrenceBusulfanTreatment OutcomeAnemia, AplasticOrgan TransplantationHistocompatibilityLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionIslets of Langerhans TransplantationGraft vs Leukemia EffectBone ResorptionLeukocyte TransfusionTime FactorsGraft vs Host ReactionSkin TransplantationPancreas TransplantationTransplantationRadiation ChimeraT-LymphocytesCell TransplantationLymphocyte DepletionRetrospective StudiesRemission InductionLeukemia, Myeloid, AcuteMice, Inbred C57BLTransplantation TolerancePrecursor Cell Lymphoblastic Leukemia-LymphomaAcute DiseaseBone NeoplasmsPeripheral Blood Stem Cell TransplantationCyclosporineBone DevelopmentSurvival AnalysisLiving DonorsBone DiseasesCytomegalovirus InfectionsCord Blood Stem Cell TransplantationCyclophosphamideTransplantation, HeterotopicIsoantigensMice, Inbred BALB CLymphocyte Culture Test, MixedSurvival RateChimeraHLA AntigensCombined Modality TherapyMyelodysplastic SyndromesFollow-Up StudiesLymphocyte TransfusionHematopoietic Stem CellsHepatic Veno-Occlusive DiseaseLeukemia, MyeloidBone RegenerationHeart-Lung TransplantationTacrolimusNuclear FamilyPostoperative ComplicationsTissue and Organ ProcurementBone MatrixHematologic DiseasesFatal OutcomeActuarial AnalysisAntilymphocyte SerumHematopoiesisFetal Tissue TransplantationImmune ToleranceChimerismLymphocyte ActivationSpleenLiver Failure